Swiss National Bank Theravance Biopharma, Inc. Transaction History

Swiss National Bank

  • $143 Billion
  • Q2 2024

A detailed history of Swiss National Bank transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Swiss National Bank holds 71,742 shares of TBPH stock, worth $581,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,742
Previous 73,742 2.71%
Holding current value
$581,110
Previous $661,000 8.02%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$8.29 - $9.92 $16,580 - $19,840
-2,000 Reduced 2.71%
71,742 $608,000
Q1 2024

May 07, 2024
SELL
$8.22 - $11.59 $78,912 - $111,264
-9,600 Reduced 11.52%
73,742 $661,000
Q4 2023

Feb 06, 2024
SELL
$8.58 - $11.4 $220,506 - $292,980
-25,700 Reduced 23.57%
83,342 $936,000
Q1 2023

May 10, 2023
SELL
$9.87 - $11.44 $290,178 - $336,336
-29,400 Reduced 21.24%
109,042 $1.18 Million
Q4 2022

Feb 08, 2023
BUY
$9.65 - $11.34 $29,915 - $35,154
3,100 Added 2.29%
138,442 $1.55 Million
Q3 2022

Nov 09, 2022
BUY
$8.39 - $10.22 $39,433 - $48,034
4,700 Added 3.6%
135,342 $1.37 Million
Q1 2022

May 09, 2022
BUY
$8.33 - $12.96 $77,469 - $120,528
9,300 Added 7.66%
130,642 $1.25 Million
Q4 2021

Feb 08, 2022
BUY
$7.42 - $11.05 $17,066 - $25,415
2,300 Added 1.93%
121,342 $1.34 Million
Q2 2021

Aug 06, 2021
BUY
$14.52 - $22.46 $242,484 - $375,082
16,700 Added 16.32%
119,042 $1.73 Million
Q1 2021

May 07, 2021
BUY
$16.57 - $21.08 $38,111 - $48,483
2,300 Added 2.3%
102,342 $2.09 Million
Q3 2020

Nov 09, 2020
BUY
$14.79 - $22.49 $41,412 - $62,971
2,800 Added 2.88%
100,042 $1.48 Million
Q2 2020

Aug 05, 2020
BUY
$20.64 - $30.69 $303,408 - $451,143
14,700 Added 17.81%
97,242 $2.04 Million
Q1 2020

May 08, 2020
BUY
$17.84 - $31.21 $21,408 - $37,452
1,200 Added 1.48%
82,542 $1.91 Million
Q4 2019

Feb 06, 2020
BUY
$16.12 - $25.89 $37,076 - $59,547
2,300 Added 2.91%
81,342 $2.11 Million
Q3 2019

Nov 12, 2019
BUY
$16.51 - $23.78 $28,067 - $40,426
1,700 Added 2.2%
79,042 $1.54 Million
Q2 2019

Aug 02, 2019
SELL
$15.6 - $25.15 $53,040 - $85,510
-3,400 Reduced 4.21%
77,342 $1.26 Million
Q1 2019

May 10, 2019
BUY
$22.57 - $28.15 $63,196 - $78,820
2,800 Added 3.59%
80,742 $1.83 Million
Q4 2018

Feb 13, 2019
BUY
$22.52 - $35.07 $63,056 - $98,196
2,800 Added 3.73%
77,942 $2 Million
Q1 2018

May 04, 2018
BUY
$23.37 - $29.71 $88,806 - $112,898
3,800 Added 5.33%
75,142 $1.82 Million
Q3 2017

Nov 03, 2017
BUY
$23.88 - $34.96 $1.7 Million - $2.49 Million
71,342
71,342 $2.44 Million

Others Institutions Holding TBPH

# of Institutions
134
Shares Held
48.7M
Call Options Held
13.9K
Put Options Held
3.1K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $541M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email